Quest Diagnostics’ Post

Longitudinal resistance data like this depends on stable, high-quality sequencing workflows. The signal only becomes meaningful when labs can rule out noise from shifts in sample quality, collection patterns or assay updates over time. One question that stands out is how much of the year-to-year variability came from true epidemiologic change versus operational factors in the testing pipeline. Which of those contributed most to the trends you observed?